| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 59, 8-13, Copyright © 1979 by American Heart Association
WB Kannel and DL McGee
The impact of cardiovascular disease was compared in non-diabetics and
diabetics in the Framingham cohort. In the first 20 years of the study
about 6% of the women and 8% of the men were diagnosed as diabetics. The
incidence of cardiovascular disease among diabetic men was twice that among
non-diabetic men. Among diabetic women the incidence of cardiovascular
disease was three times that among non-diabetic women. Judging from a
comparison of standardized coefficients for the regression of incidence of
cardiovascular disease on specified risk factors, there is no indication
that the relationship of risk factors to the subsequent development of
cardiovascular disease is different for diabetics and non-diabetics. This
study suggests that the role of diabetes as a cardiovascular risk factor
does not derive from an altered ability to contend with known risk factors.
ARTICLES
Diabetes and cardiovascular risk factors: the Framingham study
This article has been cited by other articles:
![]() |
K. Yang, E. R. Chasens, S. M. Sereika, and L. E. Burke Revisiting the Association Between Cardiovascular Risk Factors and Diabetes: Data From a Large Population-Based Study The Diabetes Educator, September 1, 2009; 35(5): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Verges, E. Florentin, S. Baillot-Rudoni, J.-M. Petit, M. C. Brindisi, J.-P. Pais de Barros, L. Lagrost, P. Gambert, and L. Duvillard Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes J. Lipid Res., June 1, 2009; 50(6): 1209 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hippisley-Cox, C. Coupland, J. Robson, A. Sheikh, and P. Brindle Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore BMJ, March 17, 2009; 338(mar17_2): b880 - b880. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Allen, B. E. Capps, E. C. Miller, D. R. Clemmons, and L. A. Maile Glucose-Oxidized Low-Density Lipoproteins Enhance Insulin-Like Growth Factor I-Stimulated Smooth Muscle Cell Proliferation by Inhibiting Integrin-Associated Protein Cleavage Endocrinology, March 1, 2009; 150(3): 1321 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rautio, M. Eliasson, and B. Stegmayr Favorable Trends in the Incidence and Outcome in Stroke in Nondiabetic and Diabetic Subjects: Findings From the Northern Sweden MONICA Stroke Registry in 1985 to 2003 Stroke, December 1, 2008; 39(12): 3137 - 3144. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Maile, B. E. Capps, E. C. Miller, A. W. Aday, and D. R. Clemmons Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo Diabetes, October 1, 2008; 57(10): 2637 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huelsmann, S. Neuhold, G. Strunk, D. Moertl, R. Berger, R. Prager, H. Abrahamian, M. Riedl, R. Pacher, A. Luger, et al. NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus Eur. Heart J., September 2, 2008; 29(18): 2259 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Halkos, J. D. Puskas, O. M. Lattouf, P. Kilgo, F. Kerendi, H. K. Song, R. A. Guyton, and V. H. Thourani Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tacoy, A. S. Balcioglu, S. Akinci, G. Erdem, S. A. Kocaman, T. Timurkaynak, and A. Cengel Traditional Risk Factors Are Predictive on Segmental Localization of Coronary Artery Disease Angiology, August 1, 2008; 59(4): 402 - 407. [Abstract] [PDF] |
||||
![]() |
R. W. Nesto LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach? Clin. Diabetes, January 1, 2008; 26(1): 8 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Filsoufi, P. B. Rahmanian, J. G. Castillo, J. I. Mechanick, S. K. Sharma, and D. H. Adams Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting Interactive CardioVascular and Thoracic Surgery, December 1, 2007; 6(6): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-V. Cantero, M. Portero-Otin, V. Ayala, N. Auge, M. Sanson, M. Elbaz, J.-C. Thiers, R. Pamplona, R. Salvayre, and A. Negre-Salvayre Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-{beta}: implications for diabetic atherosclerosis FASEB J, October 1, 2007; 21(12): 3096 - 3106. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth Endocrinology, September 1, 2007; 148(9): 4371 - 4384. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. van Lunteren and M. Moyer Oxidoreductase, morphogenesis, extracellular matrix, and calcium ion-binding gene expression in streptozotocin-induced diabetic rat heart Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E759 - E768. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, V. R. Drel, I. G. Obrosova, and P. Pacher Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H610 - H619. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D.L. Folmes and G. D. Lopaschuk Role of malonyl-CoA in heart disease and the hypothalamic control of obesity Cardiovasc Res, January 15, 2007; 73(2): 278 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Oram and A. M. Vaughan ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease Circ. Res., November 10, 2006; 99(10): 1031 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Johansson and H. J. Arnqvist Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1124 - E1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Zgibor, G. A. Piatt, K. Ruppert, T. J. Orchard, and M. S. Roberts Deficiencies of Cardiovascular Risk Prediction Models for Type 1 Diabetes Diabetes Care, August 1, 2006; 29(8): 1860 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Savoia, R. M. Touyz, D. H. Endemann, Q. Pu, E. A. Ko, C. De Ciuceis, and E. L. Schiffrin Angiotensin Receptor Blocker Added to Previous Antihypertensive Agents on Arteries of Diabetic Hypertensive Patients Hypertension, August 1, 2006; 48(2): 271 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bertrand, A. Ginion, C. Beauloye, A. D. Hebert, B. Guigas, L. Hue, and J.-L. Vanoverschelde AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H239 - H250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, K. V. Ramana, R. Tammali, S. K. Srivastava, and A. Bhatnagar Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes, April 1, 2006; 55(4): 901 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F Van Gaal, F. Peiffer, and D. Ballaux Reducing cardiovascular risk in patients with type 2 diabetes: the potential contribution of nicotinic acid The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 344 - 350. [Abstract] [PDF] |
||||
![]() |
A. H. Lauruschkat, B. Arnrich, A. A. Albert, J. A. Walter, B. Amann, U. P. Rosendahl, T. Alexander, and J. Ennker Prevalence and Risks of Undiagnosed Diabetes Mellitus in Patients Undergoing Coronary Artery Bypass Grafting Circulation, October 18, 2005; 112(16): 2397 - 2402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kahn, J. Buse, E. Ferrannini, and M. Stern The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care, September 1, 2005; 28(9): 2289 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsang, D. J. Hausenloy, M. M. Mocanu, R. D. Carr, and D. M. Yellon Preconditioning the Diabetic Heart: The Importance of Akt Phosphorylation Diabetes, August 1, 2005; 54(8): 2360 - 2364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Passarelli, C. Tang, T. O. McDonald, K. D. O'Brien, R. G. Gerrity, J. W. Heinecke, and J. F. Oram Advanced Glycation End Product Precursors Impair ABCA1-Dependent Cholesterol Removal From Cells Diabetes, July 1, 2005; 54(7): 2198 - 2205. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kubal, A. K. Srinivasan, A. D. Grayson, B. M. Fabri, and J. A.C. Chalmers Effect of Risk-Adjusted Diabetes on Mortality and Morbidity After Coronary Artery Bypass Surgery Ann. Thorac. Surg., May 1, 2005; 79(5): 1570 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fyhrquist, B. Dahlof, R. B. Devereux, S. E. Kjeldsen, S. Julius, G. Beevers, U. de Faire, H. Ibsen, K. Kristianson, O. Lederballe-Pedersen, et al. Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy Hypertension, April 1, 2005; 45(4): 580 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Ramana, B. Friedrich, R. Tammali, M. B. West, A. Bhatnagar, and S. K. Srivastava Requirement of Aldose Reductase for the Hyperglycemic Activation of Protein Kinase C and Formation of Diacylglycerol in Vascular Smooth Muscle Cells Diabetes, March 1, 2005; 54(3): 818 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, G. W. Stone, T. D. Stuckey, C. O. Costantini, P. J. Zimetbaum, M. McLaughlin, R. Mehran, E. Garcia, J. E. Tcheng, D. A. Cox, et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction J. Am. Coll. Cardiol., February 15, 2005; 45(4): 508 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sharma and S. J Brecker Dobutamine stress echocardiography in diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2005; 5(1): 42 - 46. [Abstract] [PDF] |
||||
![]() |
H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart Arch Intern Med, September 13, 2004; 164(16): 1737 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Whittemore, G. D. Melkus, A. Sullivan, and M. Grey A Nurse-Coaching Intervention for Women With Type 2 Diabetes The Diabetes Educator, September 1, 2004; 30(5): 795 - 804. [PDF] |
||||
![]() |
M. S. Farvid, M. Jalali, F. Siassi, N. Saadat, and M. Hosseini The Impact of Vitamins and/or Mineral Supplementation on Blood Pressure in Type 2 Diabetes J. Am. Coll. Nutr., June 1, 2004; 23(3): 272 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe Women and Heart Disease: The Role of Diabetes and Hyperglycemia Arch Intern Med, May 10, 2004; 164(9): 934 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Sasso, O. Carbonara, R. Nasti, B. Campana, R. Marfella, M. Torella, G. Nappi, R. Torella, and D. Cozzolino Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose Tolerance JAMA, April 21, 2004; 291(15): 1857 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C.-W. Lau, M. K.-W. Lo, G. T.-C. Leung, F. P.-T. Choi, L. Y.-C. Yam, and K. Wasserman Altered Exercise Gas Exchange as Related to Microalbuminuria in Type 2 Diabetic Patients Chest, April 1, 2004; 125(4): 1292 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Tracey, J. L. Treadway, W. P. Magee, J. C. Sutt, R. K. McPherson, C. B. Levy, D. E. Wilder, L. J. Yu, Y. Chen, R. M. Shanker, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1177 - H1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Jain, V Wadehra, and A D Timmis Management of stable angina Postgrad. Med. J., June 1, 2003; 79(932): 332 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Sozzi, A. Elhendy, J. R.T.C. Roelandt, R. T. van Domburg, A. F.L. Schinkel, E. C. Vourvouri, J. J. Bax, J. De Sutter, A. Borghetti, and D. Poldermans Prognostic Value of Dobutamine Stress Echocardiography in Patients With Diabetes Diabetes Care, April 1, 2003; 26(4): 1074 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diamant, R. Nieuwland, R. F. Pablo, A. Sturk, J. W.A. Smit, and J. K. Radder Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus Circulation, November 5, 2002; 106(19): 2442 - 2447. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Toobert, L. A. Strycker, R. E. Glasgow, M. Barrera, and J. D. Bagdade Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial Health Educ. Res., October 1, 2002; 17(5): 574 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Grant Diabetes and cardiovascular disease: the Gordian Knot The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 347 - 348. [PDF] |
||||
![]() |
D. Liao, P. J. Asberry, J. B. Shofer, H. Callahan, C. Matthys, E. J. Boyko, D. Leonetti, S. E. Kahn, M. Austin, L. Newell, et al. Improvement of BMI, Body Composition, and Body Fat Distribution With Lifestyle Modification in Japanese Americans With Impaired Glucose Tolerance Diabetes Care, September 1, 2002; 25(9): 1504 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Krein, S. Vijan, L. M. Pogach, M. M. Hogan, and E. A. Kerr Aspirin Use and Counseling About Aspirin Among Patients With Diabetes Diabetes Care, June 1, 2002; 25(6): 965 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Rowland Yeo and W W Yeo Lipid lowering in patients with diabetes mellitus: what coronary heart disease risk threshold should be used? Heart, May 1, 2002; 87(5): 423 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and J. F. Oram Unsaturated Fatty Acids Inhibit Cholesterol Efflux from Macrophages by Increasing Degradation of ATP-binding Cassette Transporter A1 J. Biol. Chem., February 8, 2002; 277(7): 5692 - 5697. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kitabchi Acute Care of Patients With Diabetes: Preface Diabetes Spectr, January 1, 2002; 15(1): 17 - 18. [Full Text] [PDF] |
||||
![]() |
B. M. Matata and M. Galinanes Effect of Diabetes on Nitric Oxide Metabolism During Cardiac Surgery Diabetes, November 1, 2001; 50(11): 2603 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D Timmis Diabetes: Relationship to ischaemic heart disease Br. Med. Bull., October 1, 2001; 59(1): 159 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mathes The Preoperative Evaluation of the Patient With Cardiac Risk Factors for Noncardiac Surgery: Which Patients Need Further Cardiac Risk Stratification Tests? Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2001; 5(2): 154 - 165. [Abstract] [PDF] |
||||
![]() |
D. P. Lee, W. F. Fearon, and V. F. Froelicher Clinical Utility of the Exercise ECG in Patients With Diabetes and Chest Pain Chest, May 1, 2001; 119(5): 1576 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D Timmis GENERAL CARDIOLOGY: Diabetic heart disease: clinical considerations Heart, April 1, 2001; 85(4): 463 - 469. [Full Text] |
||||
![]() |
S. Ghosh, N. B. Standen, and M. Galinanes Failure to precondition pathological human myocardium J. Am. Coll. Cardiol., March 1, 2001; 37(3): 711 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Tegos, E. Kalodiki, M. M. Sabetai, and A. N. Nicolaides The Genesis of Atherosclerosis and Risk Factors: A Review Angiology, February 1, 2001; 52(2): 89 - 98. [Abstract] [PDF] |
||||
![]() |
V. Palmieri, J. N. Bella, D. K. Arnett, J. E. Liu, A. Oberman, M.-Y. Schuck, D. W. Kitzman, P. N. Hopkins, D. Morgan, D. C. Rao, et al. Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects : Hypertension Genetic Epidemiology Network (HyperGEN) Study Circulation, January 2, 2001; 103(1): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shurtz-Swirski, S. Sela, A. T. Herskovits, S. M. Shasha, G. Shapiro, L. Nasser, and B. Kristal Involvement of Peripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflammation in Type 2 Diabetic Patients Diabetes Care, January 1, 2001; 24(1): 104 - 110. [Abstract] [Full Text] |
||||
![]() |
I Gustafsson, P Hildebrandt, M Seibaek, T Melchior, C Torp-Pedersen, L Kober, and P Kaiser-Nielsen Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen Eur. Heart J., December 1, 2000; 21(23): 1937 - 1943. [Abstract] [PDF] |
||||
![]() |
P. Theroux, J. Alexander Jr, C. Pharand, E. Barr, S. Snapinn, A. F. Ghannam, and F. L. Sax Glycoprotein IIb/IIIa Receptor Blockade Improves Outcomes in Diabetic Patients Presenting With Unstable Angina/Non-ST-Elevation Myocardial Infarction : Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Circulation, November 14, 2000; 102(20): 2466 - 2472. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Whang, J. T. Bigger Jr., and The CABG Patch Trial Investigators and Coordinator Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1166 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mullen, D. Wright, A. E. Donald, S. Thorne, H. Thomson, and J. E. Deanfield Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study J. Am. Coll. Cardiol., August 1, 2000; 36(2): 410 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Saito, A. R. Folsom, F. L. Brancati, B. B. Duncan, L. E. Chambless, and P. G. McGovern Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study Ann Intern Med, July 18, 2000; 133(2): 81 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
J W Sayer, B Marchant, S V Gelding, J A Cooper, and A D Timmis Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease Heart, February 1, 2000; 83(2): 210 - 216. [Abstract] [Full Text] |
||||
![]() |
S. H. Carlson, J. Shelton, C. R. White, and J. M. Wyss Elevated Sympathetic Activity Contributes to Hypertension and Salt Sensitivity in Diabetic Obese Zucker Rats Hypertension, January 1, 2000; 35(1): 403 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Melidonis, V. Dimopoulos, E. Lempidakis, J. Hatzissavas, G. Kouvaras, A. Stefanidis, S. Foussas, and S. Foussas Angiographic Study of Coronary Artery Disease in Diabetic Patients in Comparison with Nondiabetic Patients Angiology, December 1, 1999; 50(12): 997 - 1006. [Abstract] [PDF] |
||||
![]() |
S. M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr, and V. Fuster Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1348 - 1359. [Full Text] [PDF] |
||||
![]() |
S. M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr, and V. Fuster Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations : A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology Circulation, September 28, 1999; 100(13): 1481 - 1492. [Full Text] [PDF] |
||||
![]() |
R. A. DeFronzo Pharmacologic Therapy for Type 2 Diabetes Mellitus Ann Intern Med, August 17, 1999; 131(4): 281 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chatham, Z.-P. Gao, A. Bonen, and J. R. Forder Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes Cardiovasc Res, July 1, 1999; 43(1): 96 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Alderman, H. Cohen, and S. Madhavan Diabetes and Cardiovascular Events in Hypertensive Patients Hypertension, May 1, 1999; 33(5): 1130 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Momiyama, Y. Suzuki, F. Ohsuzu, Y. Atsumi, K. Matsuoka, and M. Kimura Maternally transmitted susceptibility to non-insulin-dependent diabetes mellitus and left ventricular hypertrophy J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1372 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Thourani, W. S. Weintraub, B. Stein, S. S.P. Gebhart, J. M. Craver, E. L. Jones, and R. A. Guyton Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting Ann. Thorac. Surg., April 1, 1999; 67(4): 1045 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimoni, P. E. Light, and R. J. French Altered ATP sensitivity of ATP-dependent K+ channels in diabetic rat hearts Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E568 - E576. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF] |
||||
![]() |
N. S. Kleiman, A. M. Lincoff, D. J. Kereiakes, D. P. Miller, F. V. Aguirre, K. M. Anderson, H. F. Weisman, R. M. Califf, and E. J. Topol Diabetes Mellitus, Glycoprotein IIb/IIIa Blockade, and Heparin : Evidence for a Complex Interaction in a Multicenter Trial Circulation, May 19, 1998; 97(19): 1912 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Del Corso, D. Moruzzo, B. Conte, M. Agelli, A. M. Romanelli, F. Pastine, M. Protti, F. Pentimone, and G. Baggiani Tortuosity, Kinking, and Coiling of the Carotid Artery: Expression of Atherosclerosis or Aging? Angiology, May 1, 1998; 49(5): 361 - 371. [Abstract] [PDF] |
||||
![]() |
P. J. Savage, S. L. Pressel, J. D. Curb, E. B. Schron, W. B. Applegate, H. R. Black, J. Cohen, B. R. Davis, P. Frost, W. Smith, et al. Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic Hypertension: The Systolic Hypertension in the Elderly Program Arch Intern Med, April 13, 1998; 158(7): 741 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W SAYER and A. D TIMMIS Investigation of coronary artery disease in diabetes: is screening of asymptomatic patients necessary? Heart, December 1, 1997; 78(6): 525 - 526. [Full Text] [PDF] |
||||
![]() |
S. L. Hazen, J. P. Gaut, F. F. Hsu, J. R. Crowley, A. d'Avignon, and J. W. Heinecke p-Hydroxyphenylacetaldehyde, the Major Product of L-Tyrosine Oxidation by the Myeloperoxidase-H2O2-Chloride System of Phagocytes, Covalently Modifies epsilon -Amino Groups of Protein Lysine Residues J. Biol. Chem., July 4, 1997; 272(27): 16990 - 16998. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Tobin, K. R. Welch-Holland, and M. J. Marchello Pancreatic Islet Transplantation Improves Body Composition, Decreases Energy Intake and Normalizes Energy Efficiency in Previously Diabetic Female Rats J. Nutr., June 1, 1997; 127(6): 1191 - 1197. [Abstract] [Full Text] |
||||
![]() |
E. A. Caracciolo, B. R. Chaitman, S. A. Forman, P. H. Stone, M. G. Bourassa, G. Sopko, N. L. Geller, and C. R. Conti Diabetics With Coronary Disease Have a Prevalence of Asymptomatic Ischemia During Exercise Treadmill Testing and Ambulatory Ischemia Monitoring Similar to That of Nondiabetic Patients : An ACIP Database Study Circulation, June 15, 1996; 93(12): 2097 - 2105. [Abstract] [Full Text] |
||||
![]() |
J. Qvist, S.-E. Johansson, and L. M. Johansson Multivariate analyses of mortality from coronary heart disease due to biological and behavioural factors Scand J Public Health, March 1, 1996; 24(1): 67 - 76. [Abstract] [PDF] |
||||
![]() |
P. J. Savage Cardiovascular Complications of Diabetes Mellitus: What We Know and What We Need To Know about Their Prevention Ann Intern Med, January 1, 1996; 124(1_Part_2): 123 - 126. [Abstract] [Full Text] |
||||
![]() |
J. G. Puig, L. M. Ruilope, and R. Ortega Antihypertensive Treatment Efficacy in Type II Diabetes Mellitus : Dissociation Between Casual and 24-Hour Ambulatory Blood Pressure Hypertension, December 1, 1995; 26(6): 1093 - 1099. [Abstract] [Full Text] |
||||
![]() |
M. E. Christe and R. L. Rodgers Cardiac Glucose and Fatty Acid Oxidation in the Streptozotocin-Induced Diabetic Spontaneously Hypertensive Rat Hypertension, February 1, 1995; 25(2): 235 - 241. [Abstract] [Full Text] |
||||
![]() |
Y. Kita, M. Shimizu, N. Sugihara, K. Shimizu, M. Miura, J. Koizumi, H. Mabuchi, and R. Takeda Abdominal Aortic Aneurysms in Familial Hypercholesterolemia--Case Reports Angiology, June 1, 1993; 44(6): 491 - 499. [Abstract] [PDF] |
||||
![]() |
S. E. Hankinson, J. M. Seddon, G. A. Colditz, M. J. Stampfer, B. Rosner, F. E. Speizer, and W. C. Willett A Prospective Study of Aspirin Use and Cataract Extraction in Women Arch Ophthalmol, April 1, 1993; 111(4): 503 - 508. [Abstract] [PDF] |
||||
![]() |
C. L. Manske, R. F. Wilson, Y. Wang, and W. Thomas Prevalence of, and Risk Factors for, Angiographically Determined Coronary Artery Disease in Type I-Diabetic Patients With Nephropathy Arch Intern Med, December 1, 1992; 152(12): 2450 - 2455. [Abstract] [PDF] |
||||
![]() |
M. Hollenberg, D. T. Mangano, W. S. Browner, M. J. London, J. F. Tubau, I. M. Tateo, the Study of Perioperative Ischemia Research Group, D. T. Mangano, W. S. Browner, M. Hollenberg, et al. Predictors of Postoperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery JAMA, July 8, 1992; 268(2): 205 - 209. [Abstract] [PDF] |
||||
![]() |
L. A. Zech, E. G. Gross, G. L. Peck, and H. B. Brewer Changes in Plasma Cholesterol and Triglyceride Levels After Treatment With Oral Isotretinoin: A Prospective Study Arch Dermatol, December 1, 1983; 119(12): 987 - 993. [Abstract] [PDF] |
||||
![]() |
L. D. Ostrander Jr, D. E. Lamphiear, W. D. Block, G. W. Williams, and W. J. Carman Physiological Variables and Diabetic Status: Findings in Tecumseh, Mich Arch Intern Med, September 1, 1980; 140(9): 1215 - 1219. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1979 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |